Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.

J Diabetes Investig · 2021 · PMC8565403 · PMID 34002953

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In individuals with insulin resistance, basal–bolus insulin treatment showed a trend for greater corneal nerve regeneration compared with pioglitazone plus exenatide treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.